← SEC 公告列表 | ARDX SEC 公告 | ARDX(ARDX)

重大事件 即時報告 8-K 2026-07-02

Ardelyx 提取5,000萬美元貸款 強化資金靈活性支持戰略計劃

於 SEC 網站開啟原文

AI 繁中摘要

Ardelyx 提取 5,000 萬美元貸款,強化資金靈活性 💰 申報類型:8-K(重大事件報告) 生物製藥公司 Ardelyx(納斯達克代號:ARDX)於 2026 年 6 月 29 日根據其與 SLR Investment Corp. 等貸款方簽訂的貸款及擔保協議(經多次修訂),提取第二期 F 貸款(Term F Loan),金額為 5,000 萬美元。 該筆資金將用於一般企業用途,並提升財務靈活性以支持公司 ongoing 的戰略計劃,符合 Ardelyx 的資本配置策略。貸款協議最早於 2022 年 2 月簽訂,其後分別在 2022 年 8 月、2023 年 2 月、2023 年 10 月、2024 年 10 月、2025 年 6 月及 2026 年 4 月進行修訂。 貸款條款重點: - 到期日:2030 年 7 月 1 日 - 利率:4.55% 加上 1 個月 SOFR 參考利率與 3.5% 兩者中較高者(即下限為 8.05%) - 還款安排:僅支付利息至 2030 年 7 月 1 日,到期一次還本 - 違約事件:若未能按時還款、違反契約、發生重大不利變化、破產或無力償債等,貸款方可要求立即償還並行使擔保權益(包括公司現金);違約期間將額外收取 4% 年息的違約利率 對投資者的潛在影響: 今次提款進一步補充 Ardelyx 的現金儲備,有助延長資金跑道,支持商業化推廣及研發項目。然而,貸款利率偏高(下限達 8.05%),且須於 2030 年一次過償還本金,財務槓桿有所增加。投資者需留意公司在未來數年能否產生足夠現金流,以應對還款壓力及避免觸發違約條款。整體而言,短期流動性獲提升,但中長期償債風險值得關注。
展開英文正文
ardx-202606290001437402false00014374022026-06-292026-06-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 29, 2026

ARDELYX, INC.
(Exact name of registrant as specified in its charter)

Delaware001-3648526-1303944
(State or other jurisdiction
of incorporation)(Commission
File Number)(IRS Employer
Identification Number)

400 FIFTH AVE., SUITE 210, WALTHAM, MASSACHUSETTS 02451
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code: (617) 675-2739

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareARDXThe Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Item 2.03    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

On June 29, 2026, Ardelyx, Inc. (the “Company”) received $50.0 million of funding (the “Term F Loan”) pursuant to the loan and security agreement entered into in February 2022 by and between the Company and SLR Investment Corp., as collateral agent (the “Agent”) and the lenders listed in the agreement (collectively, the “Lenders”), as amended in August 2022, February 2023, October 2023, October 2024, June 2025 and April 2026 (collectively, the “Loan Agreement”). The Company elected to draw down the Term F Loan for general corporate purposes and to enhance flexibility to support its ongoing strategic initiatives, in line with the Company’s capital allocation strategy.

In accordance with the Loan Agreement, the Term F Loan maturity date is July 1, 2030, and bears an interest rate of the sum of 4.55% plus the greater of (a) the 1-month SOFR reference rate or (b) 3.5%. The Company is permitted to make interest-only payments on the Term F Loan until July 1, 2030.

In addition, the Loan Agreement contains customary events of default that entitle the Agent to cause the Company’s indebtedness under the Loan Agreement to become immediately due and payable, and to exercise remedies against the Company and the collateral securing Term F Loan, including the Company’s cash. Under the Loan Agreement, an event of default will occur if, among other things, the Company fails to make payments under the Loan Agreement, the Company breaches any of its covenants under the Loan Agreement, subject to specified cure periods with respect to certain breaches, certain Lenders determine that a material adverse change has occurred, the Company or its assets become subject to certain legal proceedings, such as bankruptcy proceedings, the Company is unable to pay its debts as they become due or the Company defaults on contracts with third parties which would permit the holder of indebtedness to accelerate the maturity of such indebtedness or that could have a material adverse change on the Company. Upon the occurrence and for the duration of an event of default, an additional default interest rate equal to 4.0% per annum will apply to all obligations owed under the Loan Agreement.

Item 9.01    Financial Statements and Exhibits.
(d) Exhibits.

Exhibit
No.Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 2, 2026ARDELYX, INC.

By:/s/ Susan Hohenleitner
Susan Hohenleitner
Chief Financial Officer